Last: | $94.62 |
---|---|
Change Percent: | 0.22% |
Open: | $94.49 |
Close: | $94.62 |
High: | $95.02 |
Low: | $94.32 |
Volume: | 34,442,649 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$94.62 | $94.49 | $94.62 | $95.02 | $94.32 | 34,442,649 | 03-28-2024 |
$94.7 | $93.99 | $94.7 | $94.7 | $93.94 | 50,157,816 | 03-27-2024 |
$93.77 | $93.51 | $93.77 | $93.87 | $93.2813 | 34,422,997 | 03-26-2024 |
$93.51 | $93.707 | $93.51 | $93.75 | $93.3 | 24,011,759 | 03-25-2024 |
$93.98 | $94.19 | $93.98 | $94.21 | $93.78 | 30,262,284 | 03-22-2024 |
$93.09 | $93.27 | $93.09 | $93.43 | $92.725 | 34,276,643 | 03-21-2024 |
$92.89 | $93.1 | $92.89 | $93.79 | $92.29 | 43,460,080 | 03-20-2024 |
$92.92 | $92.85 | $92.92 | $93.27 | $92.69 | 26,953,132 | 03-19-2024 |
$92.66 | $92.73 | $92.66 | $92.99 | $92.5 | 29,519,539 | 03-18-2024 |
$92.94 | $93.06 | $92.94 | $93.19 | $92.785 | 34,997,707 | 03-15-2024 |
$92.97 | $93.73 | $92.97 | $93.75 | $92.86 | 58,365,563 | 03-14-2024 |
$94.42 | $94.5 | $94.42 | $94.74 | $94.21 | 38,270,057 | 03-13-2024 |
$94.88 | $95.04 | $94.88 | $95.21 | $94.69 | 29,566,000 | 03-12-2024 |
$95.68 | $95.96 | $95.68 | $96.01 | $95.37 | 17,787,915 | 03-11-2024 |
$95.73 | $95.8 | $95.73 | $96.045 | $95.48 | 25,023,234 | 03-08-2024 |
$95.9 | $96.36 | $95.9 | $96.4 | $95.48 | 39,075,047 | 03-07-2024 |
$95.99 | $95.49 | $95.99 | $96.17 | $95.41 | 40,571,580 | 03-06-2024 |
$95.43 | $95.23 | $95.43 | $95.68 | $94.965 | 37,721,853 | 03-05-2024 |
$94.09 | $93.7 | $94.09 | $94.155 | $93.68 | 23,864,210 | 03-04-2024 |
$94.47 | $93.44 | $94.47 | $94.51 | $93.01 | 45,832,788 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
iShares 20+ Year Treasury Bond ETF Company Name:
TLT Stock Symbol:
NASDAQ Market:
TORONTO, ON / ACCESSWIRE / March 27, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds (" PDC...
The bond market is showing new signs of unpredictability as expectations over Fed rate cuts shift with every new piece of economic data. Last week,...
TORONTO, ON / ACCESSWIRE / March 26, 2024 / Theralase® Technologies Inc. (" Theralase® " or the " Company ") ( TSXV:TLT )( OTCQB:TLTFF ), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (" PDCs ") and their asso...